These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 34618172)

  • 21. RapidArc vs intensity-modulated radiation therapy for hepatocellular carcinoma: a comparative planning study.
    Park JM; Kim K; Chie EK; Choi CH; Ye SJ; Ha SW
    Br J Radiol; 2012 Jul; 85(1015):e323-9. PubMed ID: 22745211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
    Hoegen-Saßmannshausen P; Naumann P; Hoffmeister-Wittmann P; Ben Harrabi S; Seidensaal K; Weykamp F; Mielke T; Ellerbrock M; Habermehl D; Springfeld C; Dill MT; Longerich T; Schirmacher P; Mehrabi A; Chang DH; Hörner-Rieber J; Jäkel O; Haberer T; Combs SE; Debus J; Herfarth K; Liermann J
    JHEP Rep; 2024 Jun; 6(6):101063. PubMed ID: 38737600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiation-induced liver disease after three-dimensional conformal radiotherapy for patients with hepatocellular carcinoma: dosimetric analysis and implication.
    Cheng JC; Wu JK; Huang CM; Liu HS; Huang DY; Cheng SH; Tsai SY; Jian JJ; Lin YM; Cheng TI; Horng CF; Huang AT
    Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):156-62. PubMed ID: 12182986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Joint Optimization of Photon-Carbon Ion Treatments for Glioblastoma.
    Bennan ABA; Unkelbach J; Wahl N; Salome P; Bangert M
    Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):559-572. PubMed ID: 34058258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.
    Hsieh CH; Liu CY; Shueng PW; Chong NS; Chen CJ; Chen MJ; Lin CC; Wang TE; Lin SC; Tai HC; Tien HJ; Chen KH; Wang LY; Hsieh YP; Huang DY; Chen YJ
    Radiat Oncol; 2010 May; 5():40. PubMed ID: 20492727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-classic radiation-induced liver disease after intensity-modulated radiotherapy for Child-Pugh grade B patients with locally advanced hepatocellular carcinoma.
    Li JX; Zhang RJ; Qiu MQ; Yan LY; He ML; Long MY; Zhong JH; Lu HY; Zhou HM; Xiang BD; Liang SX
    Radiat Oncol; 2023 Mar; 18(1):48. PubMed ID: 36890592
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment Planning Comparison for Carbon Ion Radiotherapy, Proton Therapy and Intensity-modulated Radiotherapy for Spinal Sarcoma.
    Matsumoto K; Nakamura K; Shioyama Y; Sasaki T; Ohga S; Yamaguchi T; Yoshitake T; Asai K; Kakiuchi G; Honda H
    Anticancer Res; 2015 Jul; 35(7):4083-9. PubMed ID: 26124359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of dose distribution between carbon ion radiotherapy and photon radiotherapy for head and neck tumor.
    Amirul Islam M; Yanagi T; Mizoe JE; Mizuno H; Tsujii H
    Radiat Med; 2008 Aug; 26(7):415-21. PubMed ID: 18769999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of dosimetric variations of liver radiotherapy using deformable registration of planning CT and cone-beam CT.
    Huang P; Yu G; Chen J; Ma C; Qin S; Yin Y; Liang Y; Li H; Li D
    J Appl Clin Med Phys; 2017 Jan; 18(1):66-75. PubMed ID: 28291931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas.
    Boehling NS; Grosshans DR; Bluett JB; Palmer MT; Song X; Amos RA; Sahoo N; Meyer JJ; Mahajan A; Woo SY
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):643-52. PubMed ID: 21277111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Dose Distributions When Using Carbon Ion Radiotherapy Versus Intensity-modulated Radiotherapy for Hepatocellular Carcinoma With Macroscopic Vascular Invasion: A Retrospective Analysis.
    Shiba S; Shibuya K; Kawashima M; Okano N; Kaminuma T; Okamoto M; Kubota Y; Nakano T; Ohno T
    Anticancer Res; 2020 Jan; 40(1):459-464. PubMed ID: 31892601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
    Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
    Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intensity-modulated radiotherapy versus proton radiotherapy versus carbon ion radiotherapy for spinal bone metastases: a treatment planning study.
    Rief H; Chaudhri N; Tonndorf-Martini E; Bruckner T; Rieken S; Bostel T; Förster R; Schlampp I; Debus J; Sterzing F
    J Appl Clin Med Phys; 2015 Nov; 16(6):186–194. PubMed ID: 26699573
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of protocol target definition on the ability to spare normal tissue: an IMRT and 3D-CRT planning comparison for intraorbital tumors.
    Hein PA; Gladstone DJ; Bellerive MR; Hug EB
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1540-8. PubMed ID: 16029816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicatheter interstitial brachytherapy versus intensity modulated external beam therapy for accelerated partial breast irradiation: A comparative treatment planning study with respect to dosimetry of organs at risk.
    Major T; Stelczer G; Pesznyák C; Mészáros N; Polgár C
    Radiother Oncol; 2017 Jan; 122(1):17-23. PubMed ID: 27544819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.
    Tsegmed U; Kimura T; Nakashima T; Nakamura Y; Higaki T; Imano N; Doi Y; Kenjo M; Ozawa S; Murakami Y; Awai K; Nagata Y
    Med Dosim; 2017 Summer; 42(2):97-103. PubMed ID: 28433483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-dose hypofractionated pencil beam scanning carbon ion radiotherapy for lung tumors: Dosimetric impact of different spot sizes and robustness to interfractional uncertainties.
    Mastella E; Mirandola A; Russo S; Vai A; Magro G; Molinelli S; Barcellini A; Vitolo V; Orlandi E; Ciocca M
    Phys Med; 2021 May; 85():79-86. PubMed ID: 33984821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative biological effectiveness of carbon ion radiation therapy for early stage lung cancer.
    Jeong J; Taasti VT; Jackson A; Deasy JO
    Radiother Oncol; 2020 Dec; 153():265-271. PubMed ID: 32976878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.